Papers associated with gabarap

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 2 3 4 5 6 7 8 9 10 11 12 13 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

referenced by:

	Multiple functional neurosteroid binding sites on GABAA receptors., Chen ZW, Bracamontes JR, Budelier MM, Germann AL, Shin DJ, Kathiresan K, Qian MX, Manion B, Cheng WWL, Reichert DE, Akk G, Covey DF, Evers AS., PLoS Biol. March 7, 2019; 17 (3): e3000157.
	Interaction of insecticides with heteromeric GABA-gated chloride channels from zebrafish Danio rerio (Hamilton)., Huang QT, Sheng CW, Jiang J, Tang T, Jia ZQ, Han ZJ, Zhao CQ., J Hazard Mater. March 15, 2019; 366 643-650.
	Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold., Guerrini G, Vergelli C, Cantini N, Giovannoni MP, Daniele S, Mascia MP, Martini C, Crocetti L., Int J Mol Sci. March 21, 2019; 20 (6):
	Ketone body modulation of ligand-gated ion channels., Pflanz NC, Daszkowski AW, James KA, Mihic SJ., Neuropharmacology. April 1, 2019; 148 21-30.
	Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites., Szabo A, Nourmahnad A, Halpin E, Forman SA., Mol Pharmacol. April 1, 2019; 95 (4): 408-417.
	Functional genomics of epilepsy-associated mutations in the GABAA receptor subunits reveal that one mutation impairs function and two are catastrophic., Absalom NL, Ahring PK, Liao VW, Balle T, Jiang T, Anderson LL, Arnold JC, McGregor IS, Bowen MT, Chebib M., J Biol Chem. April 12, 2019; 294 (15): 6157-6171.
	Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model., Sun LL, Yang TY, Wei NN, Lu W, Jiao WX, Zhou QQ, Miao YZ, Gao Q, Wang XT, Sun Q, Wang K., Acta Pharmacol Sin. June 1, 2019; 40 (6): 737-745.
	Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors., Mansikkamäki S, Sinkkonen ST, Korpi ER, Lüddens H., Eur J Pharmacol. June 15, 2019; 853 247-255.
	Involvement of the GABAA receptor α subunit in the mode of action of etifoxine., Mattei C, Taly A, Soualah Z, Saulais O, Henrion D, Guérineau NC, Verleye M, Legros C., Pharmacol Res. July 1, 2019; 145 104250.
	A FLIPR Assay for Discovery of GABAA Receptor Modulators of Natural Origin., Faleschini MT, Maier A, Fankhauser S, Thasis K, Hebeisen S, Hamburger M, Butterweck V., Planta Med. August 1, 2019; 85 (11-12): 925-933.
	Steady-State Activation and Modulation of the Concatemeric α1β2γ2L GABAA Receptor., Germann AL, Pierce SR, Burbridge AB, Steinbach JH, Akk G., Mol Pharmacol. September 1, 2019; 96 (3): 320-329.
	Steady-state activation and modulation of the synaptic-type α1β2γ2L GABAA receptor by combinations of physiological and clinical ligands., Germann AL, Pierce SR, Senneff TC, Burbridge AB, Steinbach JH, Akk G., Physiol Rep. September 1, 2019; 7 (18): e14230.
	Natural product incarvillateine aggravates epileptic seizures by inhibiting GABAA currents., Bian X, Zhang Y, Huang B, Wang X, Wang G, Zhu Y, Liu Y, Liang J, Jia Y, Wang K., Eur J Pharmacol. September 5, 2019; 858 172496.
	Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions., Anderson LL, Absalom NL, Abelev SV, Low IK, Doohan PT, Martin LJ, Chebib M, McGregor IS, Arnold JC., Epilepsia. November 1, 2019; 60 (11): 2224-2234.
	Steady-state activation of the high-affinity isoform of the α4β2δ GABAA receptor., Pierce SR, Senneff TC, Germann AL, Akk G., Sci Rep. November 5, 2019; 9 (1): 15997.
	Drug-selective Anesthetic Insensitivity of Zebrafish Lacking γ-Aminobutyric Acid Type A Receptor β3 Subunits., Yang X, Jounaidi Y, Mukherjee K, Fantasia RJ, Liao EC, Yu B, Forman SA., Anesthesiology. December 1, 2019; 131 (6): 1276-1291.
	Binding site location on GABAA receptors determines whether mixtures of intravenous general anaesthetics interact synergistically or additively in vivo., Kent DE, Savechenkov PY, Bruzik KS, Miller KW., Br J Pharmacol. December 1, 2019; 176 (24): 4760-4772.
	Cloning and Expression of Cockroach α7 Nicotinic Acetylcholine Receptor Subunit., Cartereau A, Taillebois E, Selvam B, Martin C, Graton J, Le Questel JY, Thany SH., Front Physiol. January 1, 2020; 11 418.
	Competitive Antagonism of Etomidate Action by Diazepam., McGrath M, Hoyt H, Pence A, Jayakar SS, Zhou X, Forman SA, Cohen JB, Miller KW, Raines DE., Anesthesiology. January 1, 2020; 133 (3): 583-594.
	The effects of a competitive antagonist on GABA-evoked currents in the presence of sedative-hypnotic agents., McGrath M, Tolia M, Raines DE., Pharmacol Rep. February 1, 2020; 72 (1): 260-266.
	Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) acutely affect human α1β2γ2L GABAA receptor and spontaneous neuronal network function in vitro., Tukker AM, Bouwman LMS, van Kleef RGDM, Hendriks HS, Legler J, Westerink RHS., Sci Rep. March 24, 2020; 10 (1): 5311.
	Reduced neurosteroid potentiation of GABAA receptors in epilepsy and depolarized hippocampal neurons., Joshi S, Roden WH, Kapur J, Jansen LA., Ann Clin Transl Neurol. April 1, 2020; 7 (4): 527-542.
	Functional characterization of the antiepileptic drug candidate, padsevonil, on GABAA receptors., Niespodziany I, Ghisdal P, Mullier B, Wood M, Provins L, Kaminski RM, Wolff C., Epilepsia. May 1, 2020; 61 (5): 914-923.
	A potent photoreactive general anesthetic with novel binding site selectivity for GABAA receptors., Shalabi AR, Yu Z, Zhou X, Jounaidi Y, Chen H, Dai J, Kent DE, Feng HJ, Forman SA, Cohen JB, Bruzik KS, Miller KW., Eur J Med Chem. May 15, 2020; 194 112261.
	Cofactor-enabled functional expression of fruit fly, honeybee, and bumblebee nicotinic receptors reveals picomolar neonicotinoid actions., Ihara M, Furutani S, Shigetou S, Shimada S, Niki K, Komori Y, Kamiya M, Koizumi W, Magara L, Hikida M, Noguchi A, Okuhara D, Yoshinari Y, Kondo S, Tanimoto H, Niwa R, Sattelle DB, Matsuda K., Proc Natl Acad Sci U S A. July 14, 2020; 117 (28): 16283-16291.
	Erythropoietin Increases GABAA Currents in Human Cortex from TLE Patients., Roseti C, Cifelli P, Ruffolo G, Barbieri E, Guescini M, Esposito V, Di Gennaro G, Limatola C, Giovannelli A, Aronica E, Palma E., Neuroscience. July 15, 2020; 439 153-162.
	Rare Diseases of Neurodevelopment: Maintain the Mystery or Use a Dazzling Tool for Investigation? The Case of Rett Syndrome., Ruffolo G, Cifelli P, Miranda-Lourenço C, De Felice E, Limatola C, Sebastião AM, Diógenes MJ, Aronica E, Palma E., Neuroscience. July 15, 2020; 439 146-152.
	Differential Coassembly of α1-GABAARs Associated with Epileptic Encephalopathy., Hannan S, Affandi AHB, Minere M, Jones C, Goh P, Warnes G, Popp B, Trollmann R, Nizetic D, Smart TG., J Neurosci. July 15, 2020; 40 (29): 5518-5530.
	Site-specific effects of neurosteroids on GABAA receptor activation and desensitization., Sugasawa Y, Cheng WW, Bracamontes JR, Chen ZW, Wang L, Germann AL, Pierce SR, Senneff TC, Krishnan K, Reichert DE, Covey DF, Akk G, Evers AS., Elife. September 21, 2020; 9
	Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites., Germann AL, Reichert DE, Burbridge AB, Pierce SR, Evers AS, Steinbach JH, Akk G., Mol Pharmacol. October 1, 2020; 98 (4): 280-291.
	The desensitization pathway of GABAA receptors, one subunit at a time., Gielen M, Barilone N, Corringer PJ., Nat Commun. October 23, 2020; 11 (1): 5369.
	PNU-120596, a positive allosteric modulator of mammalian α7 nicotinic acetylcholine receptor, is a negative modulator of ligand-gated chloride-selective channels of the gastropod Lymnaea stagnalis., Vulfius CA, Lebedev DS, Kryukova EV, Kudryavtsev DS, Kolbaev SN, Utkin YN, Tsetlin VI., J Neurochem. November 1, 2020; 155 (3): 274-284.
	Apremilast regulates acute effects of ethanol and other GABAergic drugs via protein kinase A-dependent signaling., Blednov YA, Borghese CM, Dugan MP, Pradhan S, Thodati TM, Kichili NR, Harris RA, Messing RO., Neuropharmacology. November 1, 2020; 178 108220.
	In vitro and in vivo characterization of Lu AA41178: A novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disorders., Grupe M, Bentzen BH, Benned-Jensen T, Nielsen V, Frederiksen K, Jensen HS, Jacobsen AM, Skibsbye L, Sams AG, Grunnet M, Rottländer M, Bastlund JF., Eur J Pharmacol. November 15, 2020; 887 173440.
	Reduced Activation of the Synaptic-Type GABAA Receptor Following Prolonged Exposure to Low Concentrations of Agonists: Relationship between Tonic Activity and Desensitization., Pierce SR, Germann AL, Evers AS, Steinbach JH, Akk G., Mol Pharmacol. December 1, 2020; 98 (6): 762-769.
	The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrations., Devenish SO, Winters BL, Anderson LL, Arnold JC, McGregor IS, Vaughan CW, Chebib M, Absalom NL., Neuropharmacology. January 1, 2021; 182 108371.
	A Benzodiazepine Ligand with Improved GABAA Receptor α5-Subunit Selectivity Driven by Interactions with Loop C., Simeone X, Koniuszewski F, Müllegger M, Smetka A, Steudle F, Puthenkalam R, Ernst M, Scholze P., Mol Pharmacol. January 1, 2021; 99 (1): 39-48.
	GABAA Receptors Expressed in Oligodendrocytes Cultured from the Neonatal Rat Contain α3 and γ1 Subunits and Present Differential Functional and Pharmacological Properties., Ordaz RP, Garay E, Limon A, Pérez-Samartín A, Sánchez-Gómez MV, Robles-Martínez L, Cisneros-Mejorado A, Matute C, Arellano RO., Mol Pharmacol. February 1, 2021; 99 (2): 133-146.
	'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators., Crocetti L, Guerrini G, Cantini N, Vergelli C, Melani F, Mascia MP, Giovannoni MP., Bioorg Med Chem Lett. February 15, 2021; 34 127755.
	A critical residue in the α1M2-M3 linker regulating mammalian GABAA receptor pore gating by diazepam., Nors JW, Gupta S, Goldschen-Ohm MP., Elife. February 16, 2021; 10
	Novel Three-Finger Neurotoxins from Naja melanoleuca Cobra Venom Interact with GABAA and Nicotinic Acetylcholine Receptors., Son L, Kryukova E, Ziganshin R, Andreeva T, Kudryavtsev D, Kasheverov I, Tsetlin V, Utkin Y., Toxins (Basel). February 20, 2021; 13 (2):
	Modulation of α1β3γ2 GABAA receptors expressed in X. laevis oocytes using a propofol photoswitch tethered to the transmembrane helix., Borghese CM, Wang HL, McHardy SF, Messing RO, Trudell JR, Harris RA, Bertaccini EJ., Proc Natl Acad Sci U S A. February 23, 2021; 118 (8):
	Characterization of the GABRB2-Associated Neurodevelopmental Disorders., El Achkar CM, Harrer M, Smith L, Kelly M, Iqbal S, Maljevic S, Niturad CE, Vissers LELM, Poduri A, Yang E, Lal D, Lerche H, Møller RS, Olson HE, GABRB2 Working Group., Ann Neurol. March 1, 2021; 89 (3): 573-586.
	Targeting GABAC Receptors Improves Post-Stroke Motor Recovery., van Nieuwenhuijzen PS, Parker K, Liao V, Houlton J, Kim HL, Johnston GAR, Hanrahan JR, Chebib M, Clarkson AN., Brain Sci. March 2, 2021; 11 (3):
	Dissecting the Molecular Determinants of GABAA Receptors Current Rundown, a Hallmark of Refractory Human Epilepsy., Cifelli P, Di Angelantonio S, Alfano V, Morano A, De Felice E, Aronica E, Ruffolo G, Palma E., Brain Sci. March 30, 2021; 11 (4):
	Efficient expression of concatenated α1β2δ and α1β3δ GABAA receptors, their pharmacology and stoichiometry., Liao VWY, Chebib M, Ahring PK., Br J Pharmacol. April 1, 2021; 178 (7): 1556-1573.
	Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man., Hipp JF, Knoflach F, Comley R, Ballard TM, Honer M, Trube G, Gasser R, Prinssen E, Wallace TL, Rothfuss A, Knust H, Lennon-Chrimes S, Derks M, Bentley D, Squassante L, Nave S, Nöldeke J, Wandel C, Thomas AW, Hernandez MC., Sci Rep. April 8, 2021; 11 (1): 7700.
	Substituted Cysteine Modification and Protection with n-Alkyl- Methanethiosulfonate Reagents Yields a Precise Estimate of the Distance between Etomidate and a Residue in Activated GABA Type A Receptors., Fantasia RJ, Nourmahnad A, Halpin E, Forman SA., Mol Pharmacol. June 1, 2021; 99 (6): 426-434.
	Regulation of a pentameric ligand-gated ion channel by a semiconserved cationic lipid-binding site., Sridhar A, Lummis SCR, Pasini D, Mehregan A, Brams M, Kambara K, Bertrand D, Lindahl E, Howard RJ, Ulens C., J Biol Chem. August 1, 2021; 297 (2): 100899.
	Stigmasterol can be new steroidal drug for neurological disorders: Evidence of the GABAergic mechanism via receptor modulation., Karim N, Khan I, Abdelhalim A, Halim SA, Khan A, Al-Harrasi A., Phytomedicine. September 1, 2021; 90 153646.

???pagination.result.page??? ???pagination.result.prev??? 2 3 4 5 6 7 8 9 10 11 12 13 ???pagination.result.next???